The 36-month beta value for WGS is at 2.07. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for WGS is 21.99M, and currently, shorts hold a 9.45% of that float. The average trading volume for WGS on January 14, 2025 was 646.87K shares.
WGS) stock’s latest price update
The stock of GeneDx Holdings Corp (NASDAQ: WGS) has decreased by -12.34 when compared to last closing price of 85.01.Despite this, the company has seen a loss of -16.84% in its stock price over the last five trading days. businesswire.com reported 2025-01-13 that STAMFORD, Conn.–(BUSINESS WIRE)–GeneDx Holdings Corp. (Nasdaq: WGS) today reported preliminary financial results for the fourth quarter and full year of 2024.
WGS’s Market Performance
WGS’s stock has fallen by -16.84% in the past week, with a monthly rise of 0.93% and a quarterly rise of 24.20%. The volatility ratio for the week is 12.53% while the volatility levels for the last 30 days are 8.66% for GeneDx Holdings Corp The simple moving average for the last 20 days is -8.02% for WGS’s stock, with a simple moving average of 74.80% for the last 200 days.
Analysts’ Opinion of WGS
Many brokerage firms have already submitted their reports for WGS stocks, with Wells Fargo repeating the rating for WGS by listing it as a “Equal Weight.” The predicted price for WGS in the upcoming period, according to Wells Fargo is $34 based on the research report published on August 28, 2024 of the previous year 2024.
Craig Hallum, on the other hand, stated in their research note that they expect to see WGS reach a price target of $43. The rating they have provided for WGS stocks is “Buy” according to the report published on July 10th, 2024.
Jefferies gave a rating of “Hold” to WGS, setting the target price at $21 in the report published on June 03rd of the previous year.
WGS Trading at -4.20% from the 50-Day Moving Average
After a stumble in the market that brought WGS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.63% of loss for the given period.
Volatility was left at 8.66%, however, over the last 30 days, the volatility rate increased by 12.53%, as shares surge +0.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.15% lower at present.
During the last 5 trading sessions, WGS fell by -19.36%, which changed the moving average for the period of 200-days by +663.85% in comparison to the 20-day moving average, which settled at $80.91. In addition, GeneDx Holdings Corp saw -3.04% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WGS starting from Feeley Kevin, who sale 35,506 shares at the price of $93.82 back on Jan 07 ’25. After this action, Feeley Kevin now owns 2,472 shares of GeneDx Holdings Corp, valued at $3,331,024 using the latest closing price.
Stueland Katherine, the Chief Executive Officer of GeneDx Holdings Corp, sale 51,420 shares at $94.48 during a trade that took place back on Jan 07 ’25, which means that Stueland Katherine is holding 1,720 shares at $4,858,119 based on the most recent closing price.
Stock Fundamentals for WGS
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.54 for the gross margin
The net margin for GeneDx Holdings Corp stands at -0.31. The total capital return value is set at -0.16. Equity return is now at value -36.40, with -20.21 for asset returns.
Based on GeneDx Holdings Corp (WGS), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at -0.48. The debt to equity ratio resting at 0.57. The interest coverage ratio of the stock is -16.48.
Currently, EBITDA for the company is -136.46 million with net debt to EBITDA at -1.01. When we switch over and look at the enterprise to sales, we see a ratio of 7.93. The receivables turnover for the company is 6.94for trailing twelve months and the total asset turnover is 0.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.41.
Conclusion
In conclusion, GeneDx Holdings Corp (WGS) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
